AVALO THERAPEUTICS INC's ticker is and the CUSIP is 05338F108. A total of 78 filers reported holding AVALO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $60,000 | – | 27,507 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 47,576,000 | $34,478,000 | 0.67% |
| Opaleye Management Inc. | 1,454,400 | $1,054,000 | 0.33% |
| Nantahala Capital Management | 6,849,547 | $4,804,000 | 0.21% |
| Integral Health Asset Management, LLC | 700,000 | $507,000 | 0.13% |
| Ikarian Capital, LLC | 764,271 | $554,000 | 0.07% |
| BOOTHBAY FUND MANAGEMENT, LLC | 1,198,757 | $869,000 | 0.02% |
| Point72 Asset Management, L.P. | 6,008,850 | $4,355,000 | 0.02% |
| Gyon Technologies Capital Management, LP | 18,242 | $13,000 | 0.01% |
| LEO BROKERAGE, LLC | 62,629 | $45,000 | 0.01% |
| Minot Wealth Management LLC | 34,645 | $25,000 | 0.01% |